过去一周披露的投融资案例显示，科技与制造领域依旧是一级市场关注的重点，人工智能仍是资本关注的焦点，航空航天赛道受青睐。 在科技与制造领域，湖北芯擎科技有限公司宣布完成规模超10亿元人民币的B轮融资；追梦空天科技（苏州）有限公司也宣布完成两轮累计超亿元人民币的 Pre-A++轮及战略轮融资。 医疗健康领域同样表现突出，大额融资方面，应世生物科技（南京）有限公司宣布完成超3400万美元的C轮融资，由复健资本领投，比邻星创投、澄翔资 本、昆仑资本投资，老股东恩然创投继续追加投资。 21创投不完全统计，8月18日—8月24日，报告日期内国内一级市场发生融资事件34起。其中，有27笔融资披露了融资金额和币种信息，总规模约合人民币 44.86亿元。 | 创投 215 Children | | 2025年8月18日-8月24日 国内一 | | | | --- | --- | --- | --- | --- | | | 市种 | | | 案例数(起) | | | 人民币 | | | 25 | | | 美元 | | | 2 | | | | | 注:数据由21创投根据 | | 01、芯片、人工智能完成多笔融资 本周融资数量最多的 ...

Group 1 - The core focus of investment remains on artificial intelligence and the chip sector, with significant activity in the healthcare field as well [1][3] - Hubei Chipking Technology Co., Ltd. completed a B round financing exceeding 1 billion RMB, while Dream Sky Technology (Suzhou) Co., Ltd. announced over 100 million RMB in Pre-A++ and strategic round financing [1][30][51] - In the healthcare sector, Yingshi Biotechnology (Nanjing) Co., Ltd. secured over 34 million USD in C round financing led by Rehabilitation Capital [1][18] Group 2 - The technology and manufacturing sectors saw the highest number of financing events, with the chip sector completing 4 financing rounds totaling 1.24 billion RMB, and the AI sector completing 3 rounds exceeding 59 million RMB [3][4] - The financing activities were primarily concentrated in Jiangsu Province, Beijing, and Shanghai, with 12, 6, and 5 financing events respectively [5][6] Group 3 - Qiming Venture Partners and Yunze Capital were notably active, each completing 2 financing rounds mainly in the healthcare and technology sectors [7][8] - Notable financing events include: - Beijing Huimei Cloud Technology Co., Ltd. raised nearly 200 million RMB [9] - Jiaxing Zhitong Technology Co., Ltd. completed several million RMB in A+ round financing [10] - Kegong Biotechnology (Hangzhou) Co., Ltd. raised several million RMB in A round financing [11] Group 4 - Other significant financing events include: - Microfar Biotechnology (Hangzhou) Co., Ltd. completed nearly 100 million RMB in Pre-A round financing [12] - Yixi Biotechnology (Suzhou) Co., Ltd. raised nearly 200 million RMB in A round financing [13] - Weicheng Medicine (Suzhou) Co., Ltd. secured several million USD in seed round financing [15] Group 5 - The financing landscape indicates a strong trend towards AI-driven solutions and advanced manufacturing technologies, with companies like Shenzhen Green Cloud Technology Co., Ltd. and Shanghai Kaibo Cloud Information Technology Co., Ltd. also securing significant funding [21][23] - The overall financing scale in the domestic primary market during the reported period reached approximately 4.486 billion RMB across 34 events [1][2]